Liu et al. (2023) recognized a tumor immune barrier (TIB) in an HCC tumor, located spatially near the tumor borders and consisting of CAFs, that secreted phosphoprotein 1 (SPP1)-positive macrophages and their products which may negatively affect immunotherapy efficacy. Here, SPP1 is linked to neoplasm.